Amlodipine Besylate Tablet
Product Images NDC 52605-041

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 52605-041). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Polygen Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine-structure (Amlo Structure)

Amlodipine-structure (Amlo Structure)
Chemical structure of amlodipine besylate showing its molecular framework with labeled functional groups including aromatic ring, chlorine atom, and side chains characteristic of the active ingredient.*
FDA Label Image

Amlodipine-10mg-1000count (Amlodipine 10mg 1000count)

Amlodipine-10mg-1000count (Amlodipine 10mg 1000count)
Label for Amlodipine Besylate Tablets, USP 10 mg by Polygen Pharmaceuticals Inc. The label indicates the product contains 1000 tablets, with storage instructions to keep in controlled room temperature and protect from light. The label includes dosage directions to refer to prescribing information and features a barcode and lot/expiration date fields.*
FDA Label Image

Amlodipine-10mg-90count (Amlodipine 10mg 90count)

Amlodipine-10mg-90count (Amlodipine 10mg 90count)
A drug label for Amlodipine Besylate Tablets, USP, 10 mg strength. The label includes storage instructions to keep at controlled room temperature (20° to 25°C), and protection from light. It states the product is Rx only and contains 90 tablets. The manufacturer is Polygen Pharmaceuticals Inc. located in Edgewood, New York. The label also displays a barcode and lot/expiration information areas.*
FDA Label Image

Amlo-25mg-1000count (Amlodipine 25mg 1000count)

Amlo-25mg-1000count (Amlodipine 25mg 1000count)
A rectangular medication label for amlodipine besylate tablets, USP by Polygen Pharmaceuticals Inc. It indicates the tablet strength as 2.5 mg, the dosage form as oral tablets, and a quantity of 1000 tablets. Storage instructions specify 20° to 25°C and protection from light. The label includes a barcode and manufacturer location in Edgewood, New York.*
FDA Label Image

Amlo-25mg-90count (Amlodipine 25mg 90count)

Amlo-25mg-90count (Amlodipine 25mg 90count)
Label for Amlodipine Besylate Tablets, USP, 2.5 mg strength, oral tablet form. The label specifies Rx only and a package size of 90 tablets. Manufactured by Polygen Pharmaceuticals Inc. Storage instructions indicate to keep at 20° to 25°C (68° to 77°F) and protect from light. The label includes a barcode and NDC 52605-041-19.*
FDA Label Image

Amlodipine-5mg-1000count (Amlodipine 5mg 1000count)

Amlodipine-5mg-1000count (Amlodipine 5mg 1000count)
Label for Amlodipine Besylate Tablets, USP 5 mg, oral tablet form, distributed by Polygen Pharmaceuticals Inc. The label states storage instructions, dosage form, quantity of 1000 tablets, and includes a barcode along with manufacturer location in Edgewood, New York.*
FDA Label Image

Amlodipine-5mg-90count (Amlodipine 5mg 90count)

Amlodipine-5mg-90count (Amlodipine 5mg 90count)
Label of Amlodipine Besylate Tablets, USP 5 mg from Polygen Pharmaceuticals Inc. The label states the dosage strength as 5 mg per tablet and indicates a package count of 90 tablets. It includes storage instructions, prescription-only status, and a barcode.*
FDA Label Image

Figure-1 (Graph 1)

Figure-1 (Graph 1)
A Kaplan-Meier survival curve chart comparing event rates over time in months between amlodipine and placebo groups. The y-axis shows event rate, and the x-axis shows time from 0 to 24 months with numbers at risk indicated. Amlodipine group has a lower event rate than placebo, with statistical information (p-value, hazard ratio, 95% confidence interval) included in a box.*
FDA Label Image

Figure-2 (Graph 2)

Figure-2 (Graph 2)
A forest plot showing hazard ratios with 95% confidence intervals for various patient subgroups comparing amlodipine versus placebo. Subgroups include age (<85, >=85), gender (male, female), baseline sitting systolic blood pressure (<= mean, > mean), baseline vessel disease (single, multiple), baseline vessels with stenosis, and PCI-stent status. The plot visually indicates whether each subgroup favors amlodipine or placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.